Allozyne
Latest round
- Series B
Last raised
- Oct 2007
Total raised
- $21M
Investors
- 6
About Allozyne
Allozyne, Inc.Founded in 2004 in Seattle, US, Allozyne, Inc. specializes in biotechnology solutions. The company was acquired by MedImmune, Inc.5 mn.Allozyne, Inc. provides innovative therapeutic solutions designed to meet the needs of its diverse clientele. Its product offerings include advanced therapeutics aimed at enhancing treatment efficacy across multiple therapeutic areas.The company's revenue is generated through a combination of direct sales to clients and partnerships in the biotechnology sector. The revenue model typically involves multi-year contracts, allowing for predictable revenue streams.Allozyne, Inc. aims to expand its product portfolio with new therapeutics anticipated for release following ongoing research initiatives. Plans include market expansion into Europe and Asia-Pacific within the next two years.5 mn will bolster these initiatives, providing resources necessary for product development and market penetration.
Who invested in Allozyne
6 investors across 2 rounds
See all investors in Allozyne
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allozyne
Who invested in Allozyne?
Allozyne has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allozyne raised?
Allozyne has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Allozyne last raise money?
Allozyne's most recent round on record is a Series B, in Oct 2007.
What does Allozyne do?
Allozyne is a biotechnology company.
Where is Allozyne headquartered?
Allozyne is headquartered in Seattle, US.
Which VCs invest in companies like Allozyne?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allozyne's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Allozyne? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.